Literature DB >> 9028771

Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern.

L Björklund1, I Strömberg.   

Abstract

When patients with Parkinson's disease initially show symptoms, approximately 80-85% of their dopaminergic nerve fibers in the striatum have degenerated. It is thus of importance to develop strategies to try to rescue the remaining dopaminergic neurons and to stimulate them to induce sprouting. In this study the goal was to examine whether the different subgroups of dopaminergic neurons in the ventral mesencephalon projecting to the basal ganglia have different sprouting capacities when stimulated by the trophic effect of a fetal striatal graft. Lateral ganglionic eminence was implanted into the lateral ventricle, the midportion of dorsal striatum, globus pallidus, or ventral striatum. Solid tissue pieces from 13- to 15-mm fetuses were stereotactically implanted into adult female Sprague-Dawley rats. At postgrafting week 4 the animals were perfused and processed for tyrosine hydroxylase (TH) immunohistochemistry. Transplants placed in the lateral ventricle were TH-negative, except for two cases with TH-positive fibers where the ependymal layer was disrupted, thereby allowing direct contact between the graft and the adjacent host striatum. The transplants placed into dorsal striatum were innervated by small patches of dopaminergic nerve fibers. Areas between the TH-positive patchy structures remained TH-negative. In grafts placed into globus pallidus, both patchy structures and a less dense TH-positive nerve fiber network was noted. The TH-positive growth pattern in transplants placed in ventral striatum was also divided into patchy and widespread growth. Grafts placed in globus pallidus and ventral striatum revealed significantly larger areas of TH-positive innervation compared with that measured in grafts placed in dorsal striatum and the lateral ventricle. In conclusion, it is possible to induce sprouting of TH-immunoreactive nerve fibers from all areas examined. The most potent areas to initiate dopaminergic growth were the globus pallidus and ventral striatum, where both a patchy dense and a widespread, less dense growth was induced. Thus, if using a trophic stimulus to induce sprouting from remaining dopaminergic nerve fibers in Parkinson's disease, the preferential target to induce sprouting would be ventromedial striatum and growth would be guided toward dorsal striatum owing to the enhanced dopaminergic growth properties in the ventromedial areas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028771     DOI: 10.1007/bf02454138

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  70 in total

1.  Late prenatal ontogeny of central monoamine neurons in the rat: Fluorescence histochemical observations.

Authors:  A Seiger; L Olson
Journal:  Z Anat Entwicklungsgesch       Date:  1973-08-30

2.  Correspondence between the dopamine islands and striosomes of the mammalian striatum.

Authors:  A M Graybiel
Journal:  Neuroscience       Date:  1984-12       Impact factor: 3.590

3.  Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.

Authors:  A Björklund; U Stenevi
Journal:  Brain Res       Date:  1979-11-30       Impact factor: 3.252

4.  Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum.

Authors:  P M Carvey; L R Ptak; L Kao; H L Klawans
Journal:  Clin Neuropharmacol       Date:  1989-10       Impact factor: 1.592

5.  Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies.

Authors:  W J Freed; M J Perlow; F Karoum; A Seiger; L Olson; B J Hoffer; R J Wyatt
Journal:  Ann Neurol       Date:  1980-11       Impact factor: 10.422

6.  Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.

Authors:  O Isacson; P Brundin; F H Gage; A Björklund
Journal:  Neuroscience       Date:  1985-12       Impact factor: 3.590

7.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain.

Authors:  K D Beck; J Valverde; T Alexi; K Poulsen; B Moffat; R A Vandlen; A Rosenthal; F Hefti
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

8.  Intrastriatal grafts derived from fetal striatal primordia: II. Reconstitution of cholinergic and dopaminergic systems.

Authors:  F C Liu; A M Graybiel; S B Dunnett; R W Baughman
Journal:  J Comp Neurol       Date:  1990-05-01       Impact factor: 3.215

9.  Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence.

Authors:  P Pakzaban; T W Deacon; L H Burns; O Isacson
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture.

Authors:  T Alexi; F Hefti
Journal:  Neuroscience       Date:  1993-08       Impact factor: 3.590

View more
  3 in total

1.  Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

Authors:  D D Song; S N Haber
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Chronic wheel running-induced reduction of extinction and reinstatement of methamphetamine seeking in methamphetamine dependent rats is associated with reduced number of periaqueductal gray dopamine neurons.

Authors:  Jeffery C Sobieraj; Airee Kim; McKenzie J Fannon; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2014-10-02       Impact factor: 3.270

3.  Immunocytochemical study of the forebrain serotonergic innervation in Sardinian alcohol-preferring rats.

Authors:  Maria Antonietta Casu; Carla Pisu; Carla Lobina; Luca Pani
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.